Vertex Pharmaceuticals Incorporated Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh(BR:VRTX34)
R$96.000.00 (0.00%)
BR:VRTX34
Vertex Pharmaceuticals Incorporated Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh earnings date
R$96.00
At close:0.00 (0.00%)
Vertex Pharmaceuticals Incorporated Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh (VRTX34) Q2 2023 Earnings Report
BR:VRTX34 Q2 2023 EPS Results
- Actual EPS
- BRL 0.00
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- BRL 0.00
BR:VRTX34 Q2 2023 Revenue Results
- Actual Revenue
- BRL 12.31B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +16.29%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/01/2023
- Time
- After Close
- Conference Call
- Tuesday, August 1, 2023
BR:VRTX34 Upcoming Earnings
Vertex Pharmaceuticals Incorporated Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
BR:VRTX34 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | ―- | 0 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | ―0.00 | 0 | -100.00% (-0.00) | |
| Aug 03, 2026 | 2026 (Q2) | ―0.01 | 0 | 400.00% (+0.00) | |
| May 04, 2026 | 2026 (Q1) | ―0.00 | 0 | ― | |
| Feb 12, 2026 | 2025 (Q4) | ―0.00 | 0.01 | -80.00% (-0.00) | |
| Nov 03, 2025 | 2025 (Q3) | ―0.00 | 0.01 | -83.33% (-0.01) | |
| Aug 04, 2025 | 2025 (Q2) | ―0.00 | -0.02 | 105.56% (+0.02) | |
| May 05, 2025 | 2025 (Q1) | ―0.00 | 0.01 | -100.00% (-0.01) | |
| Feb 10, 2025 | 2024 (Q4) | ―0.00 | 0 | 0.00% (+0.00) | |
| Nov 04, 2024 | 2024 (Q3) | ―0.00 | 0 | 0.00% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
